Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dina A. Abdelhakam"'
Autor:
Perihan Hamdy Kassem, Iman Fawzy Montasser, Ramy Mohamed Mahmoud, Rasha Ahmed Ghorab, Dina A. AbdelHakam, Marium EL Sayed Ahmad Fathi, Marwa A. Abdel Wahed, Khaled Mohey, Mariam Ibrahim, Mohamed El Hadidi, Yasmine M. Masssoud, Manar Salah, Arwa Abugable, Mohamad Bahaa, Sherif El Khamisy, Mahmoud El Meteini
Publikováno v:
BMC Medical Genomics, Vol 17, Iss 1, Pp 1-19 (2024)
Abstract Background Hepatocellular carcinoma (HCC) is the most common primary liver cancer. Chronic hepatitis and liver cirrhosis lead to accumulation of genetic alterations driving HCC pathogenesis. This study is designed to explore genomic landscap
Externí odkaz:
https://doaj.org/article/b3b25e70eac842d4ba0e1112865636a9
Publikováno v:
Cancer Treatment and Research Communications, Vol 26, Iss , Pp 100306- (2021)
Background: Oncotype Dx® (ODX) is the most used prognostic and predictive assay for ER + breast cancer (BCa) and is categorized into low (< 18), intermediate (18 to 30), or high (≥31) risk of recurrence. Prosigna® is a prognostic signature to est
Externí odkaz:
https://doaj.org/article/cec070bcb39749a48660ef99656bcc30
Autor:
Heba M. Adel Abou Zaghla, Dina A. Abdelhakam, Abeer Ibrahim Abd el-Mageed, Rana Ehab Moustafa Ahmed, Manal Mohsen
Publikováno v:
The Egyptian Journal of Hospital Medicine. 89:4697-4708
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70459284e026f8efdb163e4141e8d893
https://doi.org/10.21608/ejhm.2022.260021
https://doi.org/10.21608/ejhm.2022.260021
Publikováno v:
Science progress. 104(3)
Background: As an immune modulator, vitamin D has been implicated in the coronavirus disease 2019 (COVID-19) severity. This study aimed to investigate the association between vitamin D levels and the severity of COVID-19 infection. Methods: A cross-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35966e1a798501792f050ed43c9a3877
https://pubmed.ncbi.nlm.nih.gov/34723751
https://pubmed.ncbi.nlm.nih.gov/34723751
Publikováno v:
Cancer Treatment and Research Communications, Vol 26, Iss, Pp 100306-(2021)
Background: Oncotype Dx® (ODX) is the most used prognostic and predictive assay for ER + breast cancer (BCa) and is categorized into low (< 18), intermediate (18 to 30), or high (≥31) risk of recurrence. Prosigna® is a prognostic signature to est
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd038d2704e2dcaf703044fcced61e07
https://pubmed.ncbi.nlm.nih.gov/33444922
https://pubmed.ncbi.nlm.nih.gov/33444922
Publikováno v:
Diagnostic cytopathologyREFERENCES. 49(1)
In the US, 60% to 80% of oropharyngeal squamous cell carcinomas (OPSCCs) are associated with human papillomavirus (HPV). However, until recently, no consensus existed about when and how to test for HPV in patients with head and neck cancers. We aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2e43ae346b2639a89ffe0559a19860d
https://pubmed.ncbi.nlm.nih.gov/32845095
https://pubmed.ncbi.nlm.nih.gov/32845095